Moringa oleifera / BACE/β-secretase Cancer Research Results

Moringa, Moringa oleifera: Click to Expand ⟱
Features:
The leaves, seeds, and pods of the Moringa oleifera plant contain a variety of bioactive compounds, including flavonoids, phenolic acids, and saponins, which have been shown to have anti-inflammatory, antioxidant, and anti-proliferative effects.
Moringa oleifera extracts on various types of cancer: Breast, Lung, Colon, Prostate
Moringa (Moringa oleifera) is not a single compound.
Cancer-related data are primarily from:
-Leaf extracts (polyphenols, quercetin, kaempferol)
-Isothiocyanates (e.g., moringin)
-Glucosinolates
-Alkaloids and other secondary metabolites
Mechanistically it behaves as a mixed redox-modulating phytochemical extract, not a strong direct cytotoxin.

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 NF-κB inflammatory signaling NF-κB ↓; COX-2, IL-6, TNF-α ↓ (reported) Inflammation tone ↓ R, G Anti-inflammatory / anti-survival modulation One of the more consistently reported mechanisms across tumor and inflammatory models.
2 ROS / Redox modulation (context-dependent) ROS ↑ in some tumor models (extract-dependent) ROS ↓; antioxidant protection P, R Biphasic redox modulation Leaf extracts often antioxidant; certain fractions (isothiocyanates) may elevate ROS in tumor cells.
3 Nrf2 / ARE pathway Context-dependent modulation Nrf2 ↑; antioxidant enzymes ↑ R, G Redox buffering Common polyphenol/isothiocyanate signature; tumor impact varies and may influence therapy sensitivity.
4 PI3K → AKT (± mTOR) PI3K/AKT ↓ (reported; model-dependent) ↔ R, G Growth/survival suppression Frequently secondary to inflammatory and oxidative stress pathway changes.
5 MAPK pathways (ERK / JNK / p38) Stress MAPK modulation (JNK/p38 ↑ reported) ↔ P, R, G Signal reprogramming Often associated with ROS-mediated apoptosis in tumor cells.
6 Intrinsic apoptosis (mitochondrial) ΔΨm ↓; Bax ↑; caspases ↑ (reported) ↔ (limited activation) G Cell death execution Observed in several cancer cell lines; magnitude depends on extract concentration and composition.
7 Cell-cycle arrest (G1 / G2-M) Cell-cycle arrest ↑ (reported) ↔ G Cytostasis Often associated with Cyclin/CDK modulation; phase varies by tumor model.
8 Angiogenesis signaling (VEGF) VEGF ↓ (reported in some systems) ↔ G Anti-angiogenic modulation Evidence present but less consistent than NF-κB or redox effects.
9 Invasion / metastasis (MMPs / EMT) MMP2/MMP9 ↓; migration ↓ (reported) ↔ G Anti-invasive phenotype Likely downstream of NF-κB and MAPK modulation.
10 Bioavailability / extract variability Activity varies by preparation (leaf, seed, isolate) — — Translation constraint Complex phytochemistry; systemic levels from oral intake may not match in-vitro cytotoxic concentrations.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid redox interactions)
  • R: 30 min–3 hr (acute signaling shifts)
  • G: >3 hr (gene-regulatory and phenotype-level outcomes)

Active fractions (context-dependent): Leaf polyphenols (quercetin/kaempferol-class), glucosinolates/isothiocyanates (moringin-class), and other mixed constituents. Mechanistic direction can vary by preparation (leaf vs seed; aqueous vs ethanol; standardized vs crude).
BACE/β-secretase, β-site APP-cleaving enzyme: Click to Expand ⟱
Source:
Type:
BACE stands for β-site APP-cleaving enzyme, also known as β-secretase. It plays a central role in the pathogenesis of Alzheimer’s disease by initiating the production of amyloid-β (Aβ) peptides, the primary components of amyloid plaques found in the brains of individuals with AD.
-inhibiting BACE1 reduces Aβ production.

BACE1 - Beta-Site APP Cleaving Enzyme 1 / β-Secretase 1

Abbreviation: BACE1, β-secretase, β-secretase 1

Type: Aspartyl protease / amyloidogenic APP-processing enzyme

Function: BACE1 is a membrane-associated aspartyl protease that performs the initial β-secretase cleavage of amyloid precursor protein (APP). This cleavage generates soluble APPβ and the membrane-bound C99 fragment, which is subsequently cleaved by γ-secretase to produce amyloid-β peptides including Aβ40 and Aβ42.

Alzheimer's Disease: ↑ Increased BACE1 expression or enzymatic activity promotes amyloidogenic APP processing and increases amyloid-β production. Elevated BACE1 activity has been reported in Alzheimer's disease and contributes to Aβ accumulation, plaque formation, synaptic dysfunction, and disease progression. BACE1 inhibition reduces Aβ production, although clinical BACE1 inhibitors have been limited by adverse effects related to the enzyme's normal physiological functions.
Scientific Papers found: Click to Expand⟱
3835- Moringa,    Moringa Oleifera Alleviates Aβ Burden and Improves Synaptic Plasticity and Cognitive Impairments in APP/PS1 Mice
- in-vivo, AD, NA
*antiOx↑, multiple effects such as Moringa oleifera (MO) that have strong anti-oxidative, anti-inflammatory, anticholinesterase, and neuroprotective virtues.
*Inflam↓,
*AChE↓,
*neuroP↑,
*Mood↑, MO improved behavioral deficits such as anxiety-like behavior and hyperactivity and cognitive, learning, and memory impairments.
*cognitive↑,
*memory↑,
*Aβ↓, MO treatment abrogated the Aβ burden to wild-type control mice levels via decreasing BACE1 and AEP and upregulating IDE, NEP, and LRP1 protein levels.
*BACE/β-secretase↓,
*AEP↓,
*IDE↑,
*NEP↑,
*LRP1↑,
*PSD95↑, MO improved synaptic plasticity by improving the decreased GluN2B phosphorylation, the synapse-related proteins PSD95 and synapsin1 levels, the quantity and quality of dendritic spines, and neurodegeneration in the treated mice
*STEP↓, These results suggest that MO modulates the PP2B/DARPP-32/PP1 axis to downregulate STEP activity thereby improving GluN2B Tyr1472 phosphorylation in APP/PS1 mice.
*APP↓, data suggest that MO downregulates the amyloidogenic processing of APP as well as improves Aβ clearance to decrease the Aβ burden in these mice.

3834- Moringa,    Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments
- in-vivo, AD, NA
*antiOx↑, Moringa oleifera (MO), a naturally occurring plant with high antioxidative, anti-inflammatory, and neuroprotective effects,
*Inflam↓,
*neuroP↑,
*Aβ↓, decreased Aβ production through downregulation of BACE1.
*BACE/β-secretase↓, protein level of BACE1 was also increased in the Hcy group compared with control, and MO treatment significantly reduced it to control level except for the preventive low dose of MO
*cal2↓, HHcy rats were accompanied by a decrease in calpain activity under MO treatment
*p‑tau↓, MO alleviates tau hyperphosphorylation and Aβ pathology i
*ROS↓, HHcy has been reported to induce increase oxidative stress [15] while MO reduced it
*SOD↑, However, treatment with MO significantly prevented and rescued the Hcy induced decrease in SOD activity in both serum (Fig. 1A) and hippocampal lysate
*MDA↓, MO treatment decreased the level of serum (Fig. 1C) and hippocampal (Fig. 1D) MDA elevated by the Hcy injection in the rats.
*cognitive↑, MO attenuated the cognitive impairments induced by homocysteine
*memory↑, These results indicate that MO treatment significantly prevented and improved Hcy induced learning and memory deficits.


Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   MDA↓, 1,   ROS↓, 1,   SOD↑, 1,  

Migration(tgid=13) ⓘ

APP↓, 1,   cal2↓, 1,   LRP1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

Inflam↓, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 1,   PSD95↑, 1,   p‑tau↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AEP↓, 1,   Aβ↓, 2,   BACE/β-secretase↓, 2,   IDE↑, 1,   NEP↑, 1,  

Functional Outcomes(tgid=23) ⓘ

cognitive↑, 2,   memory↑, 2,   Mood↑, 1,   neuroP↑, 2,   STEP↓, 1,  
Total Targets: 21

Scientific Paper Hit Count for: BACE/β-secretase, β-site APP-cleaving enzyme
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:209  Target#:1349  State#:%  Dir#:%
  wNotes=on  sortOrder:rid,rpid

 

Home Page